Vancouver Island Health Authority   Report issue

Government Phase 1 Phase 2 Phase 4
Founded: Victoria Canada (2001)

Organization Overview

First Clinical Trial
2011
NCT01048567
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Vancouver Island Health Authority

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis, Infectious (Phase 4)

Cerebral Infarction (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Communicable Diseases (Phase 4)

Diabetic Foot (Phase 4)

Infections (Phase 4)

Inflammatory Bowel Diseases (Phase 2)

Intestinal Diseases (Phase 2)

Ischemia (Phase 2)

Osteomyelitis (Phase 4)

Staphylococcal Infections (Phase 4)

Stroke (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8